Cerebrovascular Diseases

Latest News


CME Content


WASHINGTON -- Senator Tim Johnson, a Democrat from South Dakota, was taken to George Washington University today with a possible stroke, his office said. If Johnson, who will be 60 this month, should be incapacitated and unable to serve, it would throw into question the Democrats? takeover of the Senate by a 51 to 49 majority, scheduled for next month. The governor of South Dakota, who would appoint a new senator, is a Republican. Johnson became disoriented while speaking to reporters around noon. After Johnson walked back to his office, he did not feel well, and he was examined by the Capitol physician, who recommended hospitalization.

BIRMINGHAM, Ala. -- Patients who have a stroke at a relatively young age are less likely to have access to a doctor's care than older patients and to be able to afford prescription medications, according to researchers here.

NEW YORK -- Uncomplicated diabetes does not affect 10-year heart transplant survival, but patients with diabetes-related renal disease or stroke do not do as well, reported surgeons here.

STANFORD, Calif. -- For patients with an acute ischemic stroke who arrive at emergency department too late for thrombolysis, an MRI scan may show whether they could still benefit even though the three-hour therapy window has shut.

ABSTRACT: Establishing the time of symptom onset is essential to selecting the appropriate therapy. Intravenous tissue-type plasminogen activator (t-PA), administered within 3 hours of symptom onset, is the only FDA-approved treatment for acute ischemic stroke. Intra-arterial and combined intra-arterial-intravenous thrombolytic therapy may be considered for patients whose condition does not improve or who present within 3 to 6 hours of symptom onset. Other options for treating acute ischemic stroke are balloon angioplasty with or without stenting (for symptomatic patients with more than 50% intracranial stenosis in whom medical therapy has failed) and mechanical clot retrieval (for those with an NIH Stroke Scale score greater than 10 who present after the 3-hour window for intravenous t-PA and can be treated within 8 hours of symptom onset or who present within 3 hours of symptom onset but in whom intravenous thrombolysis is contraindicated).

ABSTRACT: Establishing the time of symptom onset is essential to selecting the appropriate therapy. Intravenous tissue-type plasminogen activator (t-PA), administered within 3 hours of symptom onset, is the only FDA-approved treatment for acute ischemic stroke. Intra-arterial and combined intra-arterial-intravenous thrombolytic therapy may be considered for patients whose condition does not improve or who present within 3 to 6 hours of symptom onset. Other options for treating acute ischemic stroke are balloon angioplasty with or without stenting (for symptomatic patients with more than 50% intracranial stenosis in whom medical therapy has failed) and mechanical clot retrieval (for those with an NIH Stroke Scale score greater than 10 who present after the 3-hour window for intravenous t-PA and can be treated within 8 hours of symptom onset or who present within 3 hours of symptom onset but in whom intravenous thrombolysis is contraindicated).

BIRMINGHAM, Ala. -- In a national sample of the general population, although weighted in favor of African Americans and the so-called stroke belt, about one in five individuals 45 or older has had undiagnosed cerebrovascular symptoms, investigators reported.

Acute infection has been known to increase the risk of arterial cardiovascular events, but the effects of acute infections on venous thromboembolic disease have not been well established. Using the self- controlled case-series method, British researchers studied data obtained from general practitioners between 1987 and 2004 to investigate whether acute respiratory and urinary tract infections transiently increased the risk of initial incidents of deep venous thrombosis (DVT) in 7278 persons and pulmonary embolism (PE) in 3755.

NEW YORK -- Stroke risk trumps age, gender or other history of heart disease in determining which atrial fibrillation patients benefit from anticoagulation, according to revised guidelines issued today by the American College of Cardiology, the American Heart Association, and the European Society of Cardiology.

TORONTO -- Perhaps patients in their 70s should be advised to play it cool on their birthdays. The excitement surrounding the event increases the risk of stroke and heart attacks, according to researchers here.

We describe a case in which a patient received thrombolytic therapy after he presented with a clinical picture consistent with submassive pulmonary embolism (PE). Two months later, a malignant peripheral nerve sheath tumor was diagnosed, and the patient died with metastatic disease. The filling defect in the left main pulmonary artery originally interpreted as PE was in fact a tumor. This case describes an unusual presentation of a rare disease (malignant peripheral nerve sheath tumor) mimicking a submassive PE.